Institutional Ownership
Chugai Pharmaceutic Unsp Adr
CUSIP 171269103COMCHGCYQ1 2026
13D / 13G Filings
0
Schedule 13D/13G on record
Beneficial Filers
0
Distinct reporting persons
Largest Stake
—
Max % of class reported
Institutional Holders
13
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
Schedule 13D (activist) & 13G (passive) 5%+ ownership filings
No 13D/13G filings on record yet
Schedule 13D/13G beneficial-ownership filings from 2020–present are ingested from SEC EDGAR. Coverage expands as the backfill and daily crawler run.
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Confluence Investment Management LLC | 47.1K | $1.30M |
| 2 | Rhumbline Advisers | 47.0K | $1.29M |
| 3 | Sterling Capital Management LLC | 40.3K | $1.09M |
| 4 | Gamma Investing LLC | 13.7K | $376.8K |
| 5 | Pnc Financial Services Group, Inc. | 10.4K | $284.9K |
| 6 | Riverbridge Partners LLC | 7.8K | $215.3K |
| 7 | Salomon & Ludwin, LLC | 1.2K | $35.9K |
| 8 | Ancora Advisors LLC | 1.1K | $29.6K |
| 9 | Thurston, Springer, Miller, Herd & Titak, Inc. | 256 | $7.0K |
| 10 | First Command Advisory Services, Inc. | 122 | $3.4K |